Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02391584 · ClinicalTrials.gov registry record · NA
XprESS Eustachian Tube Dilation Study
A NA study, sponsored by Entellus Medical.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02391584: Completed NA study, sponsored by Entellus Medical.
NCT02391584 is a NA study that has completed, run by Entellus Medical. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02391584, a NA study, has completed, sponsored by Entellus Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Study to assess the safety and efficacy of the XprESS device for transnasal Eustachian tube dilation.
Primary Outcome
Comparison of mean change in overall ETDQ-7 scores from baseline to 6 weeks between randomized arms. The 7-item Eustachian Tube Dysfunction Questionnaire (ETDQ-7) is a validated patient-reported tool measuring ETD symptoms and severity. The 7 items are: pressure in the ears, pain in the ears, a feeling that your ears are clogged or underwater, ear symptoms when you have a cold of sinusitis, cracking or popping sounds in the ear, ringing in the ears, and a feeling that your hearing is muffled. E
Interventions
- OTHER Control
- DEVICE XprESS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-10 |
| Phase | NA |
What the finished NCT02391584 record still lists
NCT02391584 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT02391584 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02391584 about?
NCT02391584 is a clinical study titled "XprESS Eustachian Tube Dilation Study". Study to assess the safety and efficacy of the XprESS device for transnasal Eustachian tube dilation.
What is the current status of trial NCT02391584?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2015-02. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02391584?
The interventions under investigation include: Control (OTHER), XprESS (DEVICE).
Who is sponsoring clinical trial NCT02391584?
This trial is sponsored by Entellus Medical, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02391584's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia